Merrimack Pharmaceuticals, Inc. MACK · Stock Open Merrimack Pharmaceuticals, Inc. in new tab
Merrimack Pharmaceuticals, Inc. Analysis (MACK)
Is Merrimack Pharmaceuticals, Inc. a good investment? Merrimack Pharmaceuticals, Inc. (MACK) is currently trading at 15.15 USD.
For income investors, Merrimack Pharmaceuticals, Inc. pays a dividend yield of 99.70%.
Investor FAQ
Does Merrimack Pharmaceuticals, Inc. pay a dividend?
Yes, it pays an annual dividend of 15.10 USD (99.70% yield).
What asset class is Merrimack Pharmaceuticals, Inc.?
Merrimack Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
Company Profile
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
| Year | Total Dividends |
|---|---|
| ▸2024 |
30.20 USD
|
| May 20, 2024 | 15.1000 |
| May 17, 2024 | 15.1000 |
| ▸2019 |
2.00 USD
|
| Dec. 23, 2019 | 0.5000 |
| Sept. 6, 2019 | 1.4967 |
| ▸2017 |
1.06 USD
|
| May 30, 2017 | 1.0552 |
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 6, 2017 | 1:10 |
| Sept. 6, 2019 | 1.27 |
Community Discussion